Emma Costante

Emma, a distinguished lawyer in the corporate commercial sector, offers her expertise to a diverse clientele, both locally and internationally. Her areas of advice span a wide spectrum, including but not limited to, business dealings, mergers, acquisitions, financial support, intricate shareholder disputes, corporate structuring, commercial agreements, collaborations, and partnerships. Further, she delves into competition law and international investment issues. Emma's practice is well-versed across numerous fields such as technology, life sciences, natural resources, healthcare, infrastructure, retail, and private equity.

Emma's portfolio showcases her involvement in significant transactions. She played a pivotal role in enGene's merger with Forbion European Acquisition Corporation, a strategic move that gathered US$138 million in proceeds. Her expertise guided Abdera through a US$110 million Series B financing, and she was instrumental in Tasktop Technologies securing C$100 million from Sumeru Equity Partners. Emma's counsel benefited Alpha-9 Theranostics and Incisive Genetics, aiding them in raising US$75 million and C$12 million in their respective financing rounds. Notch Therapeutics and Later.com also flourished under her guidance, securing substantial funds and strategic acquisitions.

In her advisory capacity, Emma has facilitated the successful IPO of AbCellera Biologics on NASDAQ, raising US$555.5 million, and supported the acquisition and financing endeavors of numerous corporations including Brewster Travel Canada, D-Wave Systems, and Beijing BDStar Navigation. Her acumen in corporate governance is evident through her advisory role in the merger of the Centre for Drug Research and Development with NEOMED Institute, forming adMare BioInnovations, and her representation of entities in complex governance and shareholder agreements.

Emma's impact extends to competition and foreign investment realms, advising GlaxoSmithKline on Canadian antitrust matters and Marine Harvest ASA on acquiring a stake in Grieg Seafood ASA. Her recognition in the legal community is affirmed by her inclusion in Best Lawyers: Ones to Watch in Canada for 2022–2023 in Corporate Law.

Her academic background is robust, with a JD from the University of Toronto and a BA from McGill University, where she was honored with the Brian Coghlan Memorial Prize in Economics. Emma's legal practice encompasses a broad array of sectors, highlighting her versatile expertise in technology and innovation, life sciences, and more. This diversity not only underscores her adaptability but also her ability to navigate complex legal landscapes effectively.